Publications by authors named "Jurij Furst"

Claim this Profile
I
Impact of the COVID-19 pandemic on antidepressant use in eleven European regions: a comparative time series analysis 2018-2022.
Iva Selke Krulichová, Adam Hallberg, Gisbert W Selke, Katri Aaltonen, Manuela Casula

Soc Psychiatry Psychiatr Epidemiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati

Biomed Res Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.
Iva Selke Krulichová, Gisbert W Selke, Marion Bennie, Mohammadhossein Hajiebrahimi, Fredrik Nyberg

Pharmacoepidemiol Drug Saf· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome-based reimbursement in Central-Eastern Europe and Middle-East.
Ildikó Ádám, Marcelien Callenbach, Bertalan Németh, Rick A Vreman, Cecilia Tollin

Front Med (Lausanne)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.
Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes

Front Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati

Biomed Res Int· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe.
Luka Vončina, Tea Strbad, Jurij Fürst, Maria Dimitrova, Maria Kamusheva

Appl Health Econ Health Policy· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Brian Godman, Andrew Hill, Steven Simoens, Gisbert Selke, Iva Selke Krulichová

Expert Rev Pharmacoecon Outcomes Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.
Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar

Front Public Health· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Two Different Analgesic Prescription Strategies and Healthcare Systems: Slovenia vs. the Netherlands.
Ajda Bedene, Anita Strmljan, Eveline L A van Dorp, Mitja Udovič, Willem M Lijfering

Front Pain Res (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Expiry of Humira Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj

Front Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Review of Managed Entry Agreements: Chances and Limitations.
Carolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, Pâmela Santos Azevedo, Marina Morgado Garcia

Pharmacoeconomics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal

Appl Health Econ Health Policy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.
Brian Godman, Mainul Haque, Judy McKimm, Muhamad Abu Bakar, Jacqueline Sneddon, Jurij Furst

Curr Med Res Opin· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Patricia Vella Bonanno, Anna Bucsics, Steven Simoens, Antony P Martin, Wija Oortwijn

Expert Rev Pharmacoecon Outcomes Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C Rothe

Front Public Health· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European challenges of funding orphan medicinal products.
Márta Szegedi, Tamás Zelei, Francis Arickx, Anna Bucsics, Emanuelle Cohn-Zanchetta

Orphanet J Rare Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications.
Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović

Front Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policies for biosimilar uptake in Europe: An overview.
Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.
Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain

Front Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, Tarik Čatić, Dávid Dankó

Pharmacoeconomics· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P Martin, Jesper Van Den Bergh

Front Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau

Front Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan

Front Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe.
Wojciech Matusewicz, Brian Godman, Hanne Bak Pedersen, Jurij Fürst, Jolanta Gulbinovič

Expert Rev Pharmacoecon Outcomes Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis